{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 1.0769258, "regularMarketPrice": 6.57, "firstTradeDateMilliseconds": 1331731800000, "priceHint": 2, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.5, "epsForward": -1.41, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -4.1320753, "sharesOutstanding": 15518000, "bookValue": -0.083, "fiftyDayAverage": 7.0446, "fiftyDayAverageChange": -0.47459984, "fiftyDayAverageChangePercent": -0.06737073, "twoHundredDayAverage": 6.54195, "twoHundredDayAverageChange": 0.028049946, "twoHundredDayAverageChangePercent": 0.004287704, "marketCap": 101953264, "forwardPE": -4.6595745, "priceToBook": -79.15663, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.07000017, "regularMarketTime": 1684180804, "regularMarketDayHigh": 6.82, "regularMarketDayRange": "6.475 - 6.82", "regularMarketDayLow": 6.475, "regularMarketVolume": 158651, "regularMarketPreviousClose": 6.5, "bid": 0.0, "ask": 0.0, "bidSize": 13, "askSize": 18, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 6.73, "averageDailyVolume3Month": 141083, "averageDailyVolume10Day": 153570, "fiftyTwoWeekLowChange": 2.3400002, "fiftyTwoWeekLowChangePercent": 0.55319154, "fiftyTwoWeekRange": "4.23 - 8.37", "fiftyTwoWeekHighChange": -1.7999997, "fiftyTwoWeekHighChangePercent": -0.21505374, "fiftyTwoWeekLow": 4.23, "fiftyTwoWeekHigh": 8.37, "dividendDate": 1577923200, "displayName": "BriaCell Therapeutics", "symbol": "BCTX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Bellevue Centre", "address2": "Suite 300 235 West 15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "fax": "604 921 1898", "website": "https://www.briacell.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams M.D.", "age": 65, "title": "CEO, Pres & Director", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 710992, "fmt": "710.99k", "longFmt": "710,992"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 459679, "fmt": "459.68k", "longFmt": "459,679"}}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A., MBA", "age": 49, "title": "CFO & Corp. Sec.", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 247091, "fmt": "247.09k", "longFmt": "247,091"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 208948, "fmt": "208.95k", "longFmt": "208,948"}}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 246616, "fmt": "246.62k", "longFmt": "246,616"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 438864, "fmt": "438.86k", "longFmt": "438,864"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 76, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}